| Structure of GRP94 in the active conformation | | homo-2-mer | 49-748 | 100.0 | 2×ANP; |
|
| Structure of full length GRP94 with AMP-PNP bound | | homo-2-mer | 85-749 | 100.0 | 5×MG; 2×ANP; |
|
| Structure of full length GRP94 with ADP bound | | homo-2-mer | 85-749 | 100.0 | 4×MG; 2×ADP; |
|
| Structure of Middle plus C-terminal domains (M+C) of GRP94 | | homo-2-mer | 340-765 | 100.0 | |
|
| GRP94 in complex with the novel HSP90 Inhibitor Radester amine | | homo-2-mer | 69-337 | 100 | 2×RDE; 8×PG4; 1×1PE; |
|
| Structure of the N-domain of GRP94 bound to the HSP90 inhibitor PU-H54 | | homo-2-mer | 69-337 | 100 | 2×P54; 4×IPA; 1×GOL; |
|
| Structure of GRP94 with a resorcinylic inhibitor. | | homo-2-mer | 70-337 | 100.0 | 6×SO4; 2×EQD; 9×EDO; |
|
| GRP94 N-terminal Domain bound to geldanamycin | | homo-2-mer | 72-337 | 100.0 | 2×GDM; 4×PG4; 1×1PE; |
|
| GRP94 in complex with the novel HSP90 Inhibitor Radamide | | homo-2-mer | 74-337 | 100.0 | 2×RDA; 4×PG4; 1×1PE; |
|
| Ligand Induced Conformational Shift in the N-terminal Domain of GRP94, Open Conformation ADP-Complex | | homo-2-mer | 76-337 | 100 | 2×MG; 2×ADP; 5×PG4; |
|
| Ligand Induced Conformational Shift in the N-terminal Domain of GRP94, Open Conformation | | homo-2-mer | 76-337 | 100 | 2×MG; 2×AMP; 5×PG4; |
|
| Ligand Induced Conformational Shifts in the N-terminal Domain of GRP94, Open Conformation Complexed… | | homo-2-mer | 76-337 | 100 | 2×MG; 2×ATP; 5×PG4; |
|
| Structure of N-terminal plus middle domains (N+M) of GRP94 | | monomer | 95-594 | 100.0 | |
|
| N-Domain Of Grp94 In Complex With the Novel Ligand N-Propyl Carboxyamido Adenosine | | monomer | 69-337 | 100.0 | 1×MG; 1×PA7; 3×PG4; 1×1PE; |
|
| Crystal Structure Of The N-Domain Of Grp94 Lacking The Charged Domain In Complex With Neca | | monomer | 69-337 | 100.0 | 1×NEC; 2×PG4; |
|
| Crystal Structure of the Unliganded Form of GRP94, the ER Hsp90: Basis for Nucleotide-Induced Confo… | | monomer | 69-337 | 100.0 | 4×PG4; |
|
| N-Domain Of Grp94 In Complex With the Novel Ligand N-(2-amino)ethyl Carboxyamido Adenosine | | monomer | 69-337 | 100.0 | 1×N5A; 3×PG4; |
|
| Crystal structure of Grp94 N-terminal domain bound to the purine inhibitor PU-H36 | | monomer | 69-337 | 100.0 | 3×MG; 1×ZUY; 1×GOL; 5×SO4; |
|
| Crystal structure of Grp94 N-terminal domain bound to the purine inhibitor PU-H71. | | monomer | 70-337 | 100.0 | 1×H71; 3×PG4; 1×CA; |
|
| Crystal Structure of the N-domain of the ER Hsp90 chaperone GRP94 in complex with the specific liga… | | monomer | 72-337 | 100.0 | 1×NEC; 1×M2M; |
|
| Crystal Structure of the N-domain of the ER Hsp90 chaperone GRP94 in complex with Radicicol | | monomer | 72-337 | 100.0 | 1×RDI; |
|
| Crystal Structure of the N-domain of the ER Hsp90 chaperone GRP94 in complex with 2-chlorodideoxyad… | | monomer | 72-337 | 100.0 | 1×CDY; 1×M2M; |
|
| Grp94 N-domain bound to NEOCA | | monomer | 73-337 | 100.0 | 2×PGE; 1×PG4; 1×N5O; |
|
| N-Domain Of Grp94, with the Charged Domain, In Complex With the Novel Ligand N-Propyl Carboxyamido … | | monomer | 73-337 | 100.0 | 1×PA7; 3×PG4; |
|
| Crystal Structure of the Unliganded Form of GRP94, the ER Hsp90: Basis for Nucleotide-Induced Confo… | | monomer | 73-337 | 100.0 | 4×PG4; |
|
| N-Domain Of Grp94 In Complex With the 2-Iodo-NECA | | monomer | 74-337 | 100.0 | 1×NEI; 5×PG4; |
|
| N-Domain Of Grp94 Lacking The Charged Domain In Complex With Radicicol | | monomer | 74-337 | 100.0 | 1×RDC; 4×PG4; 1×1PE; |
|
| GRP94 n-terminal domain bound to geldanamycin: effects of mutants 168-169 KS-AA | | monomer | 74-337 | 99.03 | 1×GDM; 1×PG4; 2×PGE; |
|
| Structure of Grp94 bound to methyl 2-[2-(2-benzylpyridin-3-yl)ethyl]-3-chloro-4,6-dihydroxybenzoate… | | monomer | 74-337 | 100.0 | 7×PE8; 2×PEG; 2×GOL; 1×VC4; |
|
| Crystal Structure of the Unliganded Form of GRP94, the ER Hsp90: Basis for Nucleotide-Induced Confo… | | monomer | 74-337 | 100.0 | 1×MG; 1×ADP; 6×PG4; |
|
| Crystal Structure of the Unliganded Form of GRP94, the ER Hsp90: Basis for Nucleotide-Induced Confo… | | monomer | 74-337 | 100.0 | 1×NEC; 3×PG4; |
|
| Structure of Grp94 with methyl 3-chloro-2-(2-(1-(2-ethoxybenzyl)-1 H-imidazol-2-yl)ethyl)-4,6-dihyd… | | monomer | 74-337 | 100.0 | 13×P33; 1×GOL; 1×V2C; |
|
| Crystal structure of Grp94 bound to isoform-selective inhibitor methyl 2-(2-(1-(4-bromobenzyl)-1H-i… | | monomer | 74-337 | 100.0 | 1×7KY; 1×PEG; |
|
| Structure of GRP94 N-terminal Domain bound to resorcinylic inhibitor BnIm. | | monomer | 74-337 | 100.0 | 4×EDO; 1×9QY; |
|
| Structure of molecular chaperone Grp94 bound to selective inhibitor methyl 3-chloro-2-(2-{2-[(4-flu… | | monomer | 74-337 | 100.0 | 1×VC1; 4×P33; |
|
| Structure of molecular chaperone Grp94 bound to selective inhibitor methyl 2-[2-(2-benzylphenyl)eth… | | monomer | 74-337 | 100.0 | 8×P33; 1×VC5; 1×GOL; |
|
| Structure of GRP94 with a selective resorcinylic inhibitor. | | monomer | 76-337 | 100.0 | 1×D57; 2×EDO; 2×PO4; |
|
| N-Domain Of Grp94 In Complex With the Novel Ligand N-(2-hydroxyl)ethyl Carboxyamido Adenosine | | monomer | 69-286 | 100.0 | 1×N5O; 4×PG4; |
|
| Crystal structure of Grp94 bound to methyl 3-chloro-2-(2-(1-((5-chlorofuran-2-yl)methyl)-1H-imidazo… | | monomer | 74-286 | 100.0 | 1×PGE; 8×GOL; 1×6C0; |
|